Healthcare provider profile · identity verified

Jane Kirker Conroy, D.O.

Family Practice · HARRISBURG, PA · NPI 1679542997

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	135
Levothyroxine Sodium	Levothyroxine Sodium	404	107
Lisinopril	Lisinopril	365	91
Amlodipine Besylate	Amlodipine Besylate	297	76
Pantoprazole Sodium	Pantoprazole Sodium	249	67
Lorazepam	Lorazepam	247	66
Citalopram Hbr	Citalopram Hydrobromide	239	54
Omeprazole	Omeprazole	239	55
Rosuvastatin Calcium	Rosuvastatin Calcium	232	64
Losartan Potassium	Losartan Potassium	222	60
Metoprolol Succinate	Metoprolol Succinate	221	58
Famotidine	Famotidine	208	53
Simvastatin	Simvastatin	195	53
Metformin Hcl	Metformin Hcl	182	55
Hydrochlorothiazide	Hydrochlorothiazide	175	43
Prednisone	Prednisone	161	117
Meloxicam	Meloxicam	159	40
Oxycodone Hcl	Oxycodone Hcl	151	suppressed
Jardiance	Empagliflozin	141	28
Furosemide	Furosemide	122	36
Synthroid	Levothyroxine Sodium	119	32
Gabapentin	Gabapentin	117	25
Amoxicillin	Amoxicillin	101	69
Tramadol Hcl	Tramadol Hcl	95	15
Ozempic	Semaglutide	94	17
Sertraline Hcl	Sertraline Hcl	94	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	88	65
Clonazepam	Clonazepam	86	14
Tamsulosin Hcl	Tamsulosin Hcl	86	19
Trazodone Hcl	Trazodone Hcl	83	21
Glimepiride	Glimepiride	80	23
Metoprolol Tartrate	Metoprolol Tartrate	80	22
Buspirone Hcl	Buspirone Hcl	79	16
Fluticasone Propionate	Fluticasone Propionate	75	28
Montelukast Sodium	Montelukast Sodium	75	23
Azelastine Hcl	Azelastine Hcl	72	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	72	54
Azithromycin	Azithromycin	69	56
Duloxetine Hcl	Duloxetine Hcl	69	18
Fluconazole	Fluconazole	68	32
Clopidogrel	Clopidogrel Bisulfate	67	19
Escitalopram Oxalate	Escitalopram Oxalate	67	16
Alprazolam	Alprazolam	66	14
Fluoxetine Hcl	Fluoxetine Hcl	64	20
Bupropion Xl	Bupropion Hcl	59	11
Eliquis	Apixaban	59	13
Ezetimibe	Ezetimibe	56	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	54	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	54	13
Venlafaxine Hcl Er	Venlafaxine Hcl	53	13
Potassium Chloride	Potassium Chloride	52	suppressed
Pravastatin Sodium	Pravastatin Sodium	48	13
Allopurinol	Allopurinol	46	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	20
Methylprednisolone	Methylprednisolone	46	34
Carvedilol	Carvedilol	45	suppressed
Metformin Hcl Er	Metformin Hcl	42	12
Valacyclovir	Valacyclovir Hcl	42	22
Valsartan	Valsartan	41	11
Donepezil Hcl	Donepezil Hcl	40	suppressed
Raloxifene Hcl	Raloxifene Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	20
Oxycontin	Oxycodone Hcl	37	suppressed
Cephalexin	Cephalexin	36	23
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	24
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	15
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Atenolol	Atenolol	30	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Ondansetron Odt	Ondansetron	30	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Celecoxib	Celecoxib	29	11
Mupirocin	Mupirocin	29	21
Baclofen	Baclofen	28	suppressed
Cefuroxime	Cefuroxime Axetil	28	18
Nystatin	Nystatin	28	14
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Clotrimazole	Clotrimazole	27	11
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Armour Thyroid	Thyroid,pork	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Estradiol	Estradiol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Ramipril	Ramipril	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Colchicine	Colchicine	14	suppressed
Invokana	Canagliflozin	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Linzess	Linaclotide	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error